The artificial heart research and development company Shenzhen Core Medical Technology Co., Ltd. has received nearly RMB100 million yuan in Series A financing, led by NAC Capital, with Puhua Capital and Yifeng Capital participating.
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech
Want to read this important story?
Access thousands of news articles and data posts over the past 9 years!
Already have an account or paid subscription? Log in
